BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1350198)

  • 1. Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer.
    Shi D; He G; Cao S; Pan W; Zhang HZ; Yu D; Hung MC
    Mol Carcinog; 1992; 5(3):213-8. PubMed ID: 1350198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
    Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF
    Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.
    Onn A; Correa AM; Gilcrease M; Isobe T; Massarelli E; Bucana CD; O'Reilly MS; Hong WK; Fidler IJ; Putnam JB; Herbst RS
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):136-43. PubMed ID: 14734462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p185(HER-2/neu) and p21(CIP1/WAF1) expression in primary tumors and lymph node metastases in non-small cell lung cancer.
    Akita K; Inagaki H; Sato S; Niimi T; Maeda H; Ninomiya S; Achiwa H; Kawaguchi H; Yamakawa Y; Fujii Y; Shimizu S; Eimoto T; Ueda R
    Jpn J Cancer Res; 2002 Sep; 93(9):1007-11. PubMed ID: 12359054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas.
    Yi ES; Harclerode D; Gondo M; Stephenson M; Brown RW; Younes M; Cagle PT
    Mod Pathol; 1997 Feb; 10(2):142-8. PubMed ID: 9127320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of c-erbB-2 and loss of p16 have molecular diagnostic relevance but no prognostic value in lung cancer.
    Feng XL; Li L; Gao YN; Zhang JJ; Xiao T; Ying JM; Gao JD; Sun YT; Cheng SJ
    Med Oncol; 2011 Mar; 28(1):336-41. PubMed ID: 20237870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
    Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
    Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells.
    Tsai CM; Levitzki A; Wu LH; Chang KT; Cheng CC; Gazit A; Perng RP
    Cancer Res; 1996 Mar; 56(5):1068-74. PubMed ID: 8640763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization.
    Tan D; Deeb G; Wang J; Slocum HK; Winston J; Wiseman S; Beck A; Sait S; Anderson T; Nwogu C; Ramnath N; Loewen G
    Diagn Mol Pathol; 2003 Dec; 12(4):201-11. PubMed ID: 14639106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.
    Bongiorno PF; Whyte RI; Lesser EJ; Moore JH; Orringer MB; Beer DG
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):590-5. PubMed ID: 7905543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of prognostic implications of HER-2/neu abnormalities in 345 stage I non-small cell carcinomas (NSCLC) and 207 stage I-III neuroendocrine tumours (NET) of the lung.
    Pelosi G; Del Curto B; Dell'Orto P; Pasini F; Veronesi G; Spaggiari L; Maisonneuve P; Iannucci A; Terzi A; Lonardoni A; Viale G
    Int J Cancer; 2005 Jan; 113(1):101-8. PubMed ID: 15386424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of the quantified expression of p185 in non-small cell lung cancer.
    Cantero R; Torres AJ; Maestro ML; Hernando F; Sanz MT; Del Barco V; Gómez A; Fernández C; Balibrea JL
    J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1119-25. PubMed ID: 10838527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of possible synergistic expression of p53 and p185 as a prognostic tool for stage I non-small-cell lung cancer.
    Cantero R; Torres AJ; Maestro M; Fernández C; Hernando F; del Barco V; Sanz T; Balibrea JL
    World J Surg; 1999 Dec; 23(12):1294-9; discussion 1299-300. PubMed ID: 10552124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues.
    Natali PG; Nicotra MR; Bigotti A; Venturo I; Slamon DJ; Fendly BM; Ullrich A
    Int J Cancer; 1990 Mar; 45(3):457-61. PubMed ID: 1968437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma.
    Jaehne J; Urmacher C; Thaler HT; Friedlander-Klar H; Cordon-Cardo C; Meyer HJ
    J Cancer Res Clin Oncol; 1992; 118(6):474-9. PubMed ID: 1352299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer.
    Cheng TL; Chang MY; Huang SY; Sheu CC; Kao EL; Cheng YJ; Chong IW
    Chest; 2005 Sep; 128(3):1453-60. PubMed ID: 16162743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas.
    Liu C; Tsao MS
    Am J Pathol; 1993 Apr; 142(4):1155-62. PubMed ID: 8097369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties.
    Yu D; Wang SS; Dulski KM; Tsai CM; Nicolson GL; Hung MC
    Cancer Res; 1994 Jun; 54(12):3260-6. PubMed ID: 7911396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular biology and immunohistochemical studies of Her2/neu oncogene in stomach cancer].
    Jähne J; Urmacher C; Albino A; Meyer HJ; Pichlmayr R
    Chirurg; 1994 Apr; 65(4):307-11. PubMed ID: 7912666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and c-erbB-2 expression in non-small-cell lung carcinoma (c-erbB-2 in non-small cell lung carcinoma).
    Bakir K; Uçak R; Tunçözgür B; Elbeyli L
    Thorac Cardiovasc Surg; 2002 Feb; 50(1):55-8. PubMed ID: 11847606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.